assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_010365305.1_ASM1036530v1	NZ_CP048279	Staphylococcus sp. MI 10-1553 chromosome, complete genome	1	140048-140521	1,1,1	PILER-CR,CRISPRCasFinder,CRT	no	cas1,cas2,cas10,csm2gr11,csm3gr7,csm4gr5,csm5gr7,csm6,cas6	cas14j,cas1,cas2,cas10,csm2gr11,csm3gr7,csm4gr5,csm5gr7,csm6,cas6,cas3,DEDDh,RT,DinG,csa3,cas9,WYL	Type III-B,Type III-D,Type III-C,Type III-A	AATCAGATAGAACCCCGTACAAAAGGGGACGAGAACT,AATCAGATAGAACCCCGTACAAAAGGGGACGAGAACT,AATCAGATAGAACCCCGTACAAAAGGGGACGAGAACT	37,37,37	0	0	NA	NA	NA:NA:NA	5,6,6	6	TypeIII-B,TypeIII-D,TypeIII-C,TypeIII-A	cas14j,cas1,cas2,cas10,csm2gr11,csm3gr7,csm4gr5,csm5gr7,csm6,cas6,cas3,DEDDh,RT,DinG,csa3,cas9,WYL	NA,NA|67aa|down_8|NZ_CP048279.1_158240_158441_+	NA|223aa|up_9|NZ_CP048279.1_130166_130835_-	COG0745, OmpR, Response regulators consisting of a CheY-like receiver domain and a winged-helix DNA-binding domain [Signal transduction mechanisms / Transcription]	cas1|303aa|up_8|NZ_CP048279.1_131246_132155_+	TIGR03639, cas1_NMENI, CRISPR-associated endonuclease Cas1, subtype II/NMENI	cas2|102aa|up_7|NZ_CP048279.1_132154_132460_+	TIGR01573, cas2, CRISPR-associated endonuclease Cas2	cas10|758aa|up_6|NZ_CP048279.1_132473_134747_+	cd09680, Cas10_III, CRISPR/Cas system-associated protein Cas10	csm2gr11|142aa|up_5|NZ_CP048279.1_134749_135175_+	cd09647, Csm2_III-A, CRISPR/Cas system-associated protein Csm2	csm3gr7|215aa|up_4|NZ_CP048279.1_135176_135821_+	cd09684, Csm3_III-A, CRISPR/Cas system-associated RAMP superfamily protein Csm3	csm4gr5|303aa|up_3|NZ_CP048279.1_135831_136740_+	TIGR01903, Hypothetical_protein	csm5gr7|335aa|up_2|NZ_CP048279.1_136743_137748_+	cd09662, Csm5_III-A, CRISPR/Cas system-associated RAMP superfamily protein Csm5	csm6|423aa|up_1|NZ_CP048279.1_137764_139033_+	TIGR02672, hypothetical_protein_SERP2456, CRISPR type III-A/MTUBE-associated protein Csm6	cas6|251aa|up_0|NZ_CP048279.1_139029_139782_+	COG5551, COG5551, CRISPR system related protein, RAMP superfamily [Defense    mechanisms]	NA|123aa|down_0|NZ_CP048279.1_142285_142654_+	COG1112, COG1112, Superfamily I DNA and RNA helicases and helicase subunits [DNA replication, recombination, and repair]	NA|284aa|down_1|NZ_CP048279.1_143085_143937_+	COG1737, RpiR, Transcriptional regulators [Transcription]	NA|657aa|down_2|NZ_CP048279.1_144038_146009_-	TIGR01995, beta-glucosides_PTS_EIIBCA, PTS system, beta-glucoside-specific IIABC component	NA|299aa|down_3|NZ_CP048279.1_146025_146922_-	PRK05441, murQ, N-acetylmuramic acid-6-phosphate etherase; Reviewed	NA|358aa|down_4|NZ_CP048279.1_146908_147982_-	pfam05913, DUF871, Bacterial protein of unknown function (DUF871)	NA|2376aa|down_5|NZ_CP048279.1_148864_155992_+	PRK12467, PRK12467, peptide synthase; Provisional	NA|220aa|down_6|NZ_CP048279.1_156002_156662_+	COG2091, Sfp, Phosphopantetheinyl transferase [Coenzyme metabolism]	NA|276aa|down_7|NZ_CP048279.1_157044_157872_+	smart00644, Ami_2, Ami_2 domain	NA|67aa|down_8|NZ_CP048279.1_158240_158441_+	NA	NA|932aa|down_9|NZ_CP048279.1_158610_161406_+	COG0610, COG0610, Type I site-specific restriction-modification system, R (restriction) subunit and related helicases [Defense mechanisms]
GCF_010365305.1_ASM1036530v1	NZ_CP048279	Staphylococcus sp. MI 10-1553 chromosome, complete genome	2	2091792-2092420	2,2,2,3	PILER-CR,CRT,CRISPRCasFinder,PILER-CR	no	cas2,cas1,cas9	cas14j,cas1,cas2,cas10,csm2gr11,csm3gr7,csm4gr5,csm5gr7,csm6,cas6,cas3,DEDDh,RT,DinG,csa3,cas9,WYL	 or Type II-C?,Type II-C,Type II-A, Type II-B,Type II-B	GTTTTACTTCTTTCTAAATAAACATAGTGCTAAAACA,NGTTTTACTTCTTTCTAAATAAACATAGTGCTAAAAC,GTTTTACTTCTTTCTAAATAAACATAGTGCTAAAAC,GTTTTACTTCTTTCTAAATAAACATAGTGCTAAAAC	37,37,36,36	0	0	NA	NA	NA:NA:NA:NA	7,9,9,7	9	orTypeII-C?,TypeII-C,TypeII-A,TypeII-B,TypeII-B	cas14j,cas1,cas2,cas10,csm2gr11,csm3gr7,csm4gr5,csm5gr7,csm6,cas6,cas3,DEDDh,RT,DinG,csa3,cas9,WYL	NA,NA|283aa|down_0|NZ_CP048279.1_2092609_2093458_-	NA|359aa|up_9|NZ_CP048279.1_2079830_2080907_-	cd06815, PLPDE_III_AR_like_1, Type III Pyridoxal 5-phosphate (PLP)-Dependent Enzyme Alanine Racemase-like 1	NA|590aa|up_8|NZ_CP048279.1_2080910_2082680_-	COG4264, RhbC, Siderophore synthetase component [Secondary metabolites biosynthesis, transport, and catabolism]	NA|395aa|up_7|NZ_CP048279.1_2082663_2083848_-	cd06173, MFS_MefA_like, Macrolide efflux protein A and similar proteins of the Major Facilitator Superfamily of transporters	NA|656aa|up_6|NZ_CP048279.1_2083948_2085916_+	COG4264, RhbC, Siderophore synthetase component [Secondary metabolites biosynthesis, transport, and catabolism]	NA|382aa|up_5|NZ_CP048279.1_2086026_2087172_+	COG2814, AraJ, Arabinose efflux permease [Carbohydrate transport and metabolism]	NA|164aa|up_4|NZ_CP048279.1_2087316_2087808_-	pfam03780, Asp23, Asp23 family, cell envelope-related function	NA|82aa|up_3|NZ_CP048279.1_2087862_2088108_-	COG5547, COG5547, Small integral membrane protein [Function unknown]	NA|181aa|up_2|NZ_CP048279.1_2088120_2088663_-	NF033218, anchor_AmaP, alkaline shock response membrane anchor protein AmaP	NA|505aa|up_1|NZ_CP048279.1_2088945_2090460_-	pfam02028, BCCT, BCCT, betaine/carnitine/choline family transporter	NA|337aa|up_0|NZ_CP048279.1_2090516_2091527_-	cd08252, AL_MDR, Arginate lyase and other MDR family members	NA|283aa|down_0|NZ_CP048279.1_2092609_2093458_-	NA	cas2|98aa|down_1|NZ_CP048279.1_2093454_2093748_-	COG3512, COG3512, CRISPR-associated protein, Cas2 homolog [Defense mechanisms]	cas1|292aa|down_2|NZ_CP048279.1_2093826_2094702_-	TIGR03639, cas1_NMENI, CRISPR-associated endonuclease Cas1, subtype II/NMENI	cas9|1335aa|down_3|NZ_CP048279.1_2094691_2098696_-	TIGR01865, conserved_hypothetical_protein, CRISPR subtype II/NMENI RNA-guided endonuclease Cas9/Csn1	NA|407aa|down_4|NZ_CP048279.1_2098950_2100171_-	COG2272, PnbA, Carboxylesterase type B [Lipid metabolism]	NA|403aa|down_5|NZ_CP048279.1_2100189_2101398_-	cd17489, MFS_YfcJ_like, Escherichia coli YfcJ, YhhS, and similar transporters of the Major Facilitator Superfamily	NA|140aa|down_6|NZ_CP048279.1_2101405_2101825_-	smart00347, HTH_MARR, helix_turn_helix multiple antibiotic resistance protein	NA|468aa|down_7|NZ_CP048279.1_2102063_2103467_-	PRK13511, PRK13511, 6-phospho-beta-galactosidase; Provisional	NA|578aa|down_8|NZ_CP048279.1_2103484_2105218_-	TIGR00394, lac_pts_IIC, phosphotransferase system, lactose specific, IIC component	NA|105aa|down_9|NZ_CP048279.1_2105223_2105538_-	TIGR00823, PTS_system_lactose-specific_IIA_component, phosphotransferase system enzyme II, lactose-specific, factor III
